Vanda Pharmaceuticals Inc.VNDANASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Trend
Trending higher.
Left:
||||
Year-over-year earnings per share growth rate
Latest
17.39%
Near historical average
Average (39q)
18.32%
Historical baseline
Range
High:1996.55%
Low:-1837.50%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 17.39% |
| Q2 2025 | 8.00% |
| Q1 2025 | -491.72% |
| Q4 2024 | 7.55% |
| Q3 2024 | -17.78% |
| Q2 2024 | -8.08% |
| Q1 2024 | -72.18% |
| Q4 2023 | -1837.50% |
| Q3 2023 | -90.94% |
| Q2 2023 | -53.51% |
| Q1 2023 | -52.50% |
| Q4 2022 | 107.61% |
| Q3 2022 | 26.75% |
| Q2 2022 | 141.45% |
| Q1 2022 | -184.62% |
| Q4 2021 | -7.14% |
| Q3 2021 | -17.65% |
| Q2 2021 | 6.25% |
| Q1 2021 | 6.67% |
| Q4 2020 | 36.36% |
| Q3 2020 | -31.25% |
| Q2 2020 | 1500.00% |
| Q1 2020 | -87.50% |
| Q4 2019 | -95.74% |
| Q3 2019 | 754.55% |
| Q2 2019 | 1996.55% |
| Q1 2019 | -105.80% |
| Q4 2018 | 42.86% |
| Q3 2018 | 55.56% |
| Q2 2018 | 28.57% |
| Q1 2018 | 271.15% |
| Q4 2017 | 59.10% |
| Q3 2017 | -191.55% |
| Q2 2017 | 79.82% |
| Q1 2017 | -1140.88% |
| Q4 2016 | -38.38% |
| Q3 2016 | 91.00% |
| Q2 2016 | 62.07% |
| Q1 2016 | 17.14% |
| Q4 2015 | -59.09% |